Study of Inorganic Nitrate Supplements to Control Blood Pressure in Pregnant Women with Chronic Hypertension Starting in the Second Trimester
Led by University of Sao Paulo · Updated on 2026-04-20
144
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
High blood pressure during pregnancy can pose serious risks to both mother and baby. This research aims to explore whether inorganic nitrate supplementation, which may help relax and widen blood vessels, can improve blood pressure control in pregnant women with chronic hypertension. Preliminary studies in animals and small groups of pregnant women have shown promising results, motivating this detailed investigation starting in the second trimester.
Participants will be randomly assigned to receive either a daily capsule containing inorganic nitrate or a placebo, starting from the 16th week of pregnancy and continuing for 22 weeks or until delivery. All participants will continue standard medication for preeclampsia prevention, including low-dose aspirin and calcium carbonate, as well as their regular blood pressure treatments. The study uses a triple-blind design, and capsules for both groups look identical.
During the study, participants will attend regular visits roughly every 4 weeks initially, increasing in frequency as delivery approaches. At these visits, they will undergo clinical exams, blood pressure checks, blood and urine tests, and ultrasound with Doppler studies of uterine arteries. Medication adjustments will be made as needed to maintain proper blood pressure. Researchers will monitor various health markers and pregnancy outcomes from the 16th week until delivery, ensuring close follow-up throughout the pregnancy period.
CONDITIONS
Brief Title
Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies
Research Team
R
Ricardo C Cavalli, Dr
P
Priscila O Barbosa, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Pregnant women diagnosed with chronic hypertension before pregnancy or before 20 weeks of gestation
Currently treated with methyldopa as monotherapy
Less than 16 weeks of gestation confirmed by first-trimester ultrasound
Female participants aged 18 years or older
You will not qualify if you...
Multiple pregnancies
Age below 18 years
Unable to provide informed consent
History of poor adherence to medication
Uncontrolled chronic hypertension with blood pressure above 160/110 mmHg
Food allergies, especially to beetroot
Use of illicit drugs, smoking, or alcohol abuse
Coronary artery disease or moderate to severe heart failure
Moderate to severe liver failure
Chronic kidney failure with creatinine clearance below 30 ml/min/1.73 m²
Pre-existing type 1 or type 2 diabetes
Frequent use of certain medications affecting stomach pH or nasal decongestants before and during the study period
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 22 weeks (154 days) or until delivery
Participants take one daily capsule containing either inorganic nitrate or placebo starting from the 16th week of pregnancy. They continue this regimen alongside standard preeclampsia prophylaxis and antihypertensive treatment until the 38th week of pregnancy or delivery, whichever comes first.
9 visits scheduled at the 16th, 20th, 24th, 28th, 32nd, 34th, 36th, 37th, and 38th weeks of pregnancy, with frequency increasing as pregnancy progresses
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluating Universal Versus Point-of-Care Antiviral Treatment to Prevent Mother-to-Child Transmission of Hepatitis B in Pregnant Women
AI-Assisted Smart Family Doctor for Managing Hypertension, Diabetes, and Dyslipidemia in Adults After Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
PILI 0ina Project to Improve Diet and Health in Native Hawaiian Adults with Cardiometabolic Conditions Through Community Cooking Demonstrations
Study of the Eat Well Produce Prescription Program for Veterans with Hypertension, Diabetes, or Obesity at Risk of Food Insecurity
Study of Vascular Function and Exercise Effects in Aging and Cardiovascular Diseases Including COPD and Pulmonary Hypertension
Community Cluster-Randomized Trial Evaluating a Hypertension Risk Model-Based Precision Intervention for Adults at High Risk in Shunyi District, Beijing
Observational Cohort Study of Biomarkers and Health Outcomes in Adults with Hypertension in Guangdong Province
Evaluation of the Hilo Band Cuffless Blood Pressure Device Compared to 24-hour Ambulatory Monitoring in Young People Aged 14 to 35
Evaluating a Digital Tool to Help Clinicians Prescribe Personalized Exercise for Adults with Cardiovascular Disease Risk Factors in a Randomized Crossover Trial
Evaluating a Telemedicine-Supported Integrated Care Model Led by Rural Doctors to Reduce Cardiovascular and Cerebrovascular Events in Older Adults at High Stroke Risk in China
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
NIT_CH: A study protocol for evaluating the effect of inorganic nitrate capsules in chronic hypertensive pregnancies - a triple-blind placebo-controlled randomized trial.